Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The fate of mitochondria during platelet activation. | Blood Adv | 2023 | 37624769 | PubTator, text mining | PubMed |
| Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity. | Front Mol Biosci | 2023 | 37602332 | PubTator, text mining | PubMed |
| Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis. | Can J Gastroenterol Hepatol | 2023 | 37588664 | PubTator, text mining | PubMed |
| Transcriptomic analysis of paired healthy human skeletal muscles to identify modulators of disease severity in DMD. | Front Genet | 2023 | 37576554 | PubTator, text mining | PubMed |
| Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective. | J Neuromuscul Dis | 2023 | 37574742 | PubTator, text mining | PubMed |
| A Genetically Engineered Bivalent Vaccine Coexpressing a Molecular Adjuvant against Classical Swine Fever and Porcine Epidemic Diarrhea. | Int J Mol Sci | 2023 | 37569329 | PubTator, text mining | PubMed |
| Microtubule-Associated Serine/Threonine (MAST) Kinases in Development and Disease. | Int J Mol Sci | 2023 | 37569286 | PubTator, text mining | PubMed |
| Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication-A Systematic Review. | J Clin Med | 2023 | 37568483 | PubTator, text mining | PubMed |
| Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer. | World J Surg Oncol | 2023 | 37563730 | PubTator, text mining | PubMed |
| Mitochondrial dynamics-related genes DRP1 and OPA1 contributes to early diagnosis of cognitive impairment in diabetes. | BMC Geriatr | 2023 | 37563583 | PubTator, text mining | PubMed |
| Cofilin-1 induces acute kidney injury via the promotion of endoplasmic reticulum stress-mediated ferroptosis. | Hum Cell | 2023 | 37548903 | PubTator, text mining | PubMed |
| Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. | Mol Neurodegener | 2023 | 37545006 | PubTator, text mining | PubMed |
| [Retracted] NR4A1 promotes TNF‑α‑induced chondrocyte death and migration injury via activating the AMPK/Drp1/mitochondrial fission pathway. | Int J Mol Med | 2023 | 37539720 | PubTator, text mining | PubMed |
| Contact sites between endoplasmic reticulum sheets and mitochondria regulate mitochondrial DNA replication and segregation. | iScience | 2023 | 37534187 | PubTator, text mining | PubMed |
| Reactive nitrogen species as therapeutic targets for autophagy/mitophagy modulation to relieve neurodegeneration in multiple sclerosis: Potential application for drug discovery. | Free Radic Biol Med | 2023 | 37532065 | PubTator, text mining | PubMed |
| Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injury. | Sci Transl Med | 2023 | 37531414 | PubTator, text mining | PubMed |
| Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. | J Hematol Oncol | 2023 | 37525282 | PubTator, text mining | PubMed |
| Natural Drugs: A New Direction for the Prevention and Treatment of Diabetes. | Molecules | 2023 | 37513397 | PubTator, text mining | PubMed |
| New Discoveries in Retinal Cell Degeneration and Retinal Diseases. | Biomolecules | 2023 | 37509157 | PubTator, text mining | PubMed |
| Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy. | Biomolecules | 2023 | 37509144 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=39